"Anyone wanna start bets on where our friend Julie will land? Eli Lilly? Merck perhaps? "
Julie's years of "looking and looking" for a vaccine/autism connection with the firm resolve of OJ Simpson looking for the real killers, asinine statements on autism in the press and denialism of an epidemic happening in front of everyone's eyes has finally paid off big for her.
Here is what we do know now... that the head of vaccines for Merck is a liar. And one who tells absurd lies and thinks that people will swallow them. In the age of vaccine skepticism, Merck was so concerned with winning the public trust that they hired the woman who was the at the helm of the autism epidemic for the last eight years.
But I am guessing that deal with the devil was made long ago.
There is no one whose actions I have had more contempt for in this health disaster than Julie Gerberding. My son regressed into autism following his vaccines on her watch. I became increasingly incensed by her actions, non-actions and thinly veiled vaccine salesmanship as the years rolled on; but I don't think down deep that even I actually believed that out of all the positions in the world she would take THE job with THE company that would truly prove beyond a shadow of a doubt that she was working for PHARMA at the expense of our kids since Bush appointed her as CDC head. If for no other reason out of embarrassment for what it would betray about her.
The woman has no shame.
The position is announced Christmas week, I guess hoping that mom's like me will be too busy trying to keep their kids with autism from eating the glass balls off the yule tree to notice. And it may be that she was legally prevented from taking the job any sooner. Email from someone who travels in these circles:
"...but based on a conversation I recently had with a friend who is a former Bush Administration official, this is pretty close to the minimum interval for how former feds can go to work with a company they regulated after leaving government. January 25th: a year and three business days after Obama’s inauguration (January 20th, 2009). January 25th 2010 is the first Monday she could start".
So as Julie ascends to this esteemed position, lets take a walk down memory lane of her disastrous reign as the chief of our nations public health services at all the bull shit she has had to offer us.
First, a critical review of the only thimerosal/autism study done under Julie's tenure:
This is one of my favorites... a video of Julie NOT lying. I was so used to her rehearsed, condescending autism denials that when I saw her talking normally about something that was actually true, that smoking is bad for you, I was a little shocked at the stark difference in her demeanor.
Merck & Co. (MRK) named former public-health authority Julie Gerberding as the head of the company's $5 billion vaccines business, starting Jan. 25.
Gerberding was the director of the U.S. Centers for Disease Control and Prevention through most of President George W. Bush's administration, from 2002 until earlier this year.
Vaccines, along with emerging markets and biologics, are an area Merck is eyeing for growth as it digests its recent acquisition of Schering-Plough Corp. The takeover was designed to help bolster Merck's research pipeline and diversify its product lineup in the face of challenges such as generic competition and setbacks in bringing new drugs to market.
Merck's previous head of vaccines, Margaret McGlynn, recently retired.
The appointment of Gerberding brings Merck a step closer to rounding out its post-Schering senior leadership team, most of which had been announced in late August but which still had a few holes. Last week, the company named a chief medical officer, Michael Rosenblatt, who had been dean of Tufts University's medical school.
Also, Merck earlier this month named Michael Kamarck as president of Merck BioVentures and senior vice president of vaccines and biologics manufacturing, said spokeswoman Amy Rose. Merck BioVentures is the unit Merck created last year to develop so-called follow-on biologics, or new versions of drugs derived from living cells.
Kamarck was previously head of technical operations and product supply at Wyeth, which was acquired by Pfizer Inc. (PFE). Frank Clyburn, who previously led Merck BioVentures, has been named senior vice president of global pharmaceuticals franchises.
Merck continues to search for a permanent head of its consumer health-care unit, a business largely inherited via the Schering deal, and which sells Coppertone sunscreen among other products. Stanley Barshay is interim leader of the business.
Merck Chairman and Chief Executive Richard Clark on Monday called Gerberding a "preeminent authority in public health, infectious diseases and vaccines."
As president of the vaccines business, she will be responsible for the sale of the company's current portfolio of vaccines, the introduction of vaccines from the company's pipeline and the acceleration of Merck's efforts to broaden vaccinations in developing countries. Gerberding will also collaborate with Merck's manufacturing division and Merck Research Laboratories to manage links between basic research, late-stage development and manufacturing.
Merck shares were recently up 2.25% at $38.24 amid a broad market rally.
-By Joan E. Solsman, Dow Jones Newswires; 212-416-2291; firstname.lastname@example.org
(Peter Loftus in Philadelphia contributed to this article.)
Again... Congratulations Julie. With your nightmare of a record and history of now confirmed corruption, I can only imagine the destruction that any product under your supervision will be able to do to the children of the world.
Un-frickin-believable... the hubris of these people.
Are there no whistle blowers that will tell the truth about what has happened from the inside? Is no one at CDC disgusted enough with this to speak up?
Just got this email from Louise Kuo Habakus at Life Health Choices:
"It’ll be old home week when she joins… Eddy Bresnitz, NJ’s former state epidemiologist and deputy commissioner of health, was responsible for mandating seasonal flu and Hib vaccines before he skipped off to Merck to head up adult vaccines".
Someone sent me this bit of info:
Julie G. also landed on this board. With Accordia, she'll be able to get the UN and Gates Foundation to pay for Merck's products for distribution in the third world.
Of course, she will continue to tap the US Treasury to transfer American tax dollars to Merck.